Abstract
Multivessel PCI is an inherently higher risk procedure than single-vessel PCI, be it a marker for poorer underlying patient health and/or the fact that there are more opportunities for complications from instrumentation. From a technical perspective, this is certainly true. When making a choice between coronary revascularization strategies, i.e., CABG or PCI, it is imperative to take into consideration both patient and procedural factors to determine the best course of action. Although guidelines and criteria exist, they are not meant to supercede physician judgment based upon a comprehensive evaluation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hartzler G (1986) Coronary angioplasty is the treatment of choice for multivessel coronary artery disease. Chest 90(6):877
Coronary angioplasty versus coronary artery bypass surgery (1993) The randomised intervention treatment of angina (RITA) trial. Lancet 341(8845):573–580
BARI Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335(4):217–225
Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb W, Lemos P, Serruys P (2008) Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 118(11):1146
Serruys P, Morice M, Kappetein A, Colombo A, Holmes D, Mack M, Ståhle E, Feldman T, van den Brand M, Bass E (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972
Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 32(17):2125–2134
Patel M, Dehmer G, Hirshfeld J, Smith P, Spertus J (2009) ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 53(6):530–553
Jolly S, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M, Valentin V, Lewis B (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377(9775):1409–1420
Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM, Investigators A (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21):2203–2216
Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL (1994) Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 90(6):2725–2730
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ahmad, I.N., Ellis, S.G. (2013). Multivessel Disease. In: Lanzer, P. (eds) Catheter-Based Cardiovascular Interventions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27676-7_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-27676-7_34
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27675-0
Online ISBN: 978-3-642-27676-7
eBook Packages: MedicineMedicine (R0)